Related Experiment Video
Updated: Oct 8, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced
J A Diamond1, L R Krakoff, A Goldman
1Section of Hypertension & Nuclear Cardiology, The Zena and Michael A. Wiener Cardiovascular Institute, the Mount Sinai Medical Center, New York, New York 10029-6574, USA. joseph.diamond@mssm.edu
Insights
Both nifedipine-GITS and verapamil-SR effectively lower blood pressure in hypertension. While both calcium channel blockers (CCB) reduce blood pressure and left ventricular mass, they show distinct effects on heart rate and neurohormonal responses.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Dihydropyridine and nondihydropyridine calcium channel blockers (CCB) possess distinct pharmacologic properties.
- Limited clinical data exists comparing CCB efficacy as monotherapy.
Purpose of the Study:
- To conduct a comprehensive comparison of nifedipine-GITS and verapamil-SR in patients with moderate to severe hypertension.
- To evaluate differences in hemodynamic profiles, neurohormonal responses, and clinical outcomes.
Main Methods:
- Thirty patients with diastolic blood pressure >= 100 mm Hg were randomized to nifedipine-GITS or verapamil-SR.
- Dose titration aimed for diastolic blood pressure <= 95 mm Hg or a >= 15 mm Hg decrease over 4 weeks.
- Assessments included clinic BP, 24-h ambulatory BP, exercise BP, echocardiography, coronary flow reserve, and plasma biomarkers.
Main Results:
- Both drugs similarly reduced clinic and 24-h ambulatory blood pressure and left ventricular mass index.
- Verapamil-SR significantly lowered resting and peak exercise heart rate compared to nifedipine-GITS.
- Nifedipine-GITS showed a lower peak exercise systolic BP and transiently reduced atrial natriuretic peptide; verapamil-SR lowered norepinephrine.
- No significant differences were observed in left ventricular function or coronary flow reserve.
Conclusions:
- Once-daily nifedipine-GITS and verapamil-SR are equally effective in reducing arterial pressure in moderate to severe hypertension.
- Observed differences in hemodynamic and neurohormonal responses align with their known preclinical pharmacologic profiles.
- Further outcome studies are needed to fully elucidate the clinical implications of these similarities and differences.
Abstract:
Dihydropyridine and nondihydropyridine calcium channel blockers (CCB) differ in pharmacologic characteristics. Few clinical studies distinguish effects of CCB as monotherapy. We conducted a comprehensive comparison of two CCB on patients with moderate to severe hypertension. Thirty patients with pretreatment diastolic blood pressures > or = 100 mm Hg were randomly assigned to either nifedipine-GITS or verapamil-SR. Dose titration achieved a diastolic blood pressure of < or = 95 mm Hg or a decrease of > or = 15 mm Hg over 4 weeks. Clinic blood pressure (BP), 24-h ambulatory BP, exercise BP, left ventricular mass, systolic and diastolic function by echocardiography, and coronary flow reserve by split-dose thallium-201 imaging with adenosine were assessed at baseline, end of titration, 3 months and 6 months of treatment. Plasma renin activity, atrial natriuretic peptide, norepinephrine, and epinephrine were assayed. Both drugs caused similar reductions in clinic and 24-h ambulatory BP and similar reductions in left ventricular mass index. Compared to nifedipine-GITS, verapamil-SR produced a significantly lower resting and peak exercise heart rate. Nifedipine-GITS elicited a lower peak exercise systolic BP. At end titration nifedipine-GITS produced lower plasma atrial natriuretic peptide levels, no longer apparent by 6 months. Plasma norepinephrine was lower with verapamil-SR, also at end titration and at 3 months, but not at 6 months. Plasma epinephrine and plasma renin activity were unchanged by either drug. There was no difference for systolic or diastolic left ventricular function or coronary flow reserve between the two treatments. Once daily nifedipine-GITS and verapamil-SR are equally effective for reduction of arterial pressure in moderate to severe hypertension. Differences in their hemodynamic profiles and neurohormonal responses are consistent with preclinical pharmacologic characteristics. The clinical implications of their similarities and differences remain to be fully evaluated in outcome studies.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Heart Failure Drugs: β-Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Vasodilators
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System